Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients
Condition: Soft Tissue Sarcoma Intervention: Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; PharmaMar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
Condition: Neoplasms Interventions: Drug: GSK3901961; Drug: Cyclophosphamide; Drug: Fludarabine Sponsor: GlaxoSmithKline Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
